These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1774279)

  • 21. Re: Spread and persistence of Clostridium difficile spores during and after cleaning with sporicidal disinfectants.
    Meyer B; Exner M; Gebel J
    J Hosp Infect; 2012 Feb; 80(2):185; author reply 186. PubMed ID: 22172407
    [No Abstract]   [Full Text] [Related]  

  • 22. The glutamate dehydrogenase gene of Clostridium symbiosum. Cloning by polymerase chain reaction, sequence analysis and over-expression in Escherichia coli.
    Teller JK; Smith RJ; McPherson MJ; Engel PC; Guest JR
    Eur J Biochem; 1992 May; 206(1):151-9. PubMed ID: 1587267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Vidas C. difficile and Quik Chek-60 glutamate dehydrogenase assays for the detection of Clostridium difficile in faecal samples.
    Carson KC; Riley TV
    Pathology; 2016 Aug; 48(5):506-8. PubMed ID: 27311869
    [No Abstract]   [Full Text] [Related]  

  • 24. Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.
    Bogaty C; Lévesque S; Garenc C; Frenette C; Bolduc D; Galarneau LA; Lalancette C; Loo V; Tremblay C; Trudeau M; Vachon J; Dionne M; Villeneuve J; Longtin J; Longtin Y;
    Am J Infect Control; 2017 Sep; 45(9):964-968. PubMed ID: 28549882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exchange of domains of glutamate dehydrogenase from the hyperthermophilic archaeon Pyrococcus furiosus and the mesophilic bacterium Clostridium difficile: effects on catalysis, thermoactivity and stability.
    Lebbink JH; Eggen RI; Geerling AC; Consalvi V; Chiaraluce R; Scandurra R; de Vos WM
    Protein Eng; 1995 Dec; 8(12):1287-94. PubMed ID: 8869641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the VIDAS glutamate dehydrogenase assay for the detection of Clostridium difficile.
    Shin BM; Lee EJ; Moon JW; Lee SY
    Anaerobe; 2016 Aug; 40():68-72. PubMed ID: 27282799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.
    Sambol SP; Merrigan MM; Lyerly D; Gerding DN; Johnson S
    Infect Immun; 2000 Oct; 68(10):5480-7. PubMed ID: 10992443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a commercially available latex immunoagglutination test kit for detection of Clostridium difficile D-1 toxin.
    Kamiya S; Nakamura S; Yamakawa K; Nishida S
    Microbiol Immunol; 1986; 30(2):177-81. PubMed ID: 3086678
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of a commercial latex agglutination assay for screening for Clostridium difficile-associated disease.
    Stella PA
    Clin Lab Sci; 1994; 7(5):311-3. PubMed ID: 10150387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile in Food and Animals: A Comprehensive Review.
    Rodriguez C; Taminiau B; Van Broeck J; Delmée M; Daube G
    Adv Exp Med Biol; 2016; 932():65-92. PubMed ID: 27350639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study.
    Vogelzang EH; Lankelma JM; van Mansfeld R; van Prehn J; van Houdt R
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1071-1076. PubMed ID: 31970532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests.
    Shanholtzer CJ; Willard KE; Holter JJ; Olson MM; Gerding DN; Peterson LR
    J Clin Microbiol; 1992 Jul; 30(7):1837-40. PubMed ID: 1629341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrence of Clostridium difficile toxin A enzyme-linked immunosorbent assay, fecal lactoferrin assay, and clinical criteria with C. difficile cytotoxin titer in two patient cohorts.
    Schleupner MA; Garner DC; Sosnowski KM; Schleupner CJ; Barrett LJ; Silva E; Hirsch D; Guerrant RL
    J Clin Microbiol; 1995 Jul; 33(7):1755-9. PubMed ID: 7665642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulsed-field gel electrophoresis can yield DNA fingerprints of degradation-susceptible Clostridium difficile strains.
    Fawley WN; Wilcox MH
    J Clin Microbiol; 2002 Sep; 40(9):3546-7; author reply 3547. PubMed ID: 12202619
    [No Abstract]   [Full Text] [Related]  

  • 35. Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea.
    Kelly MT; Champagne SG; Sherlock CH; Noble MA; Freeman HJ; Smith JA
    J Clin Microbiol; 1987 Jul; 25(7):1244-7. PubMed ID: 3611316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Glutamate Dehydrogenase (GDH) Testing Assay in the Diagnosis of Clostridium difficile Infections: A High Sensitive Screening Test and an Essential Step in the Proposed Laboratory Diagnosis Workflow for Developing Countries like China.
    Cheng JW; Xiao M; Kudinha T; Xu ZP; Sun LY; Hou X; Zhang L; Fan X; Kong F; Xu YC
    PLoS One; 2015; 10(12):e0144604. PubMed ID: 26659011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile IStron CdISt1: discovery of a variant encoding two complete transposase-like proteins.
    Hasselmayer O; Braun V; Nitsche C; Moos M; Rupnik M; von Eichel-Streiber C
    J Bacteriol; 2004 Apr; 186(8):2508-10. PubMed ID: 15060058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.
    Spigaglia P; Mastrantonio P
    J Clin Microbiol; 2002 Sep; 40(9):3470-5. PubMed ID: 12202595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis of infections caused by Clostridium difficile in the Czech Republic: availability, possibilities, and interpretation of laboratory results].
    Krůtová M; Nyč O
    Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):92-7. PubMed ID: 26099613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of toxigenic Clostridium difficile by the polymerase chain reaction.
    Kato N; Ou CY; Kato H; Bartley SL; Brown VK; Dowell VR; Ueno K
    J Clin Microbiol; 1991 Jan; 29(1):33-7. PubMed ID: 1993763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.